Skip to main content
. 2021 Aug 21;16(2):427–433. doi: 10.1007/s12105-021-01376-8

Table 1.

Tumors, tumor location, and prostate-specific membrane antigen (PSMA) positivity

Tumor Location Case number PSMA positive case (%) Matched cases of the background salivary gland (%)
PA Parotid gland 7 7 (100) 3 (43)
Submandibular gland 2 2 (100) 2 (100)
Soft palate 1 1 (100) 1 (100)
WT Parotid gland 10 10 (100) 1 (10)
BCA Parotid gland 9 8 (89) 6 (75)
ACC Tongue 3 2 (67) 1 (50)
Oral floor 2 2 (100) 2 (100)
Parotid gland 1 1 (100) 0 (0)
Submandibular gland 1 1 (100) 0 (0)
Buccal mucosa 1 1 (100) 1 (100)
Soft palate 1 1 (100) 1 (100)
MC Parotid gland 3 2 (67) 1 (50)
Gingiva 3 2 (67) 1 (50)
Soft palate 1 1 (100) 1 (100)
Hard palate 1 1 (100) 1 (100)
Tongue 1 1 (100) 1 (100)
SDC Parotid gland 7 5 (71) 3 (60)
Submandibular gland 1 0 (0) 0 (0)
Total 55 48 (87) 26 (54)

PA pleomorphic adenoma, WT Warthin tumor, BCA basal cell adenoma, ACC adenoid cystic carcinoma, MC mucoepidermoid carcinoma, SDC salivary duct carcinoma